SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-048631
Filing Date
2024-04-26
Accepted
2024-04-26 06:16:45
Documents
14
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A rphm-20231231.htm   iXBRL 10-K/A 735020
2 EX-31.3 rphm-ex31_3.htm EX-31.3 7971
3 EX-31.4 rphm-ex31_4.htm EX-31.4 7495
4 GRAPHIC img27553928_0.jpg GRAPHIC 10172
  Complete submission text file 0000950170-24-048631.txt   1032187

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rphm-20231231.xsd EX-101.SCH 44979
17 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20231231_htm.xml XML 10500
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40315 | Film No.: 24878452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)